Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 041061/0842 | |
| Pages: | 4 |
| | Recorded: | 01/24/2017 | | |
| Attorney Dkt #: | Q227152 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
5
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
14838260
|
Filing Dt:
|
08/27/2015
|
|
Publication #:
|
|
Pub Dt:
|
03/03/2016
| | | | |
|
Title:
|
Development of Protein-Based Biotherapeutics That Penetrates Cell-Membrane and Induces Anti-Hepatocellular Carcinoma Effect - Improved Cell-Permeable Suppressor of Cytokine Signaling (iCP-SOCS3) Proteins, Polynucleotides Encoding the Same, and Anti-Hepatocellular Carcinoma Compositions Comprising the Same
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
14838280
|
Filing Dt:
|
08/27/2015
|
|
Publication #:
|
|
Pub Dt:
|
03/03/2016
| | | | |
|
Title:
|
Development of Protein-Based Biotherapeutics That Penetrates Cell-Membrane and Induces Anti-Lung Cancer Effect - Improved Cell-Permeable Suppressor of Cytokine Signaling (iCP-SOCS3) Proteins, Polynucleotides Encoding the Same, and Anti-Lung Cancer Compositions Comprising the Same
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
14838288
|
Filing Dt:
|
08/27/2015
|
|
Publication #:
|
|
Pub Dt:
|
03/03/2016
| | | | |
|
Title:
|
Development of Protein-Based Biotherapeutics That Penetrates Cell-Membrane and Induces Anti-Pancreatic Cancer Effect - Improved Cell-Permeable Suppressor of Cytokine Signaling (iCP-SOCS3) Proteins, Polynucleotides Encoding the Same, and Anti-Pancreatic Cancer Compositions Comprising the Same
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
14838295
|
Filing Dt:
|
08/27/2015
|
|
Publication #:
|
|
Pub Dt:
|
03/03/2016
| | | | |
|
Title:
|
Development of Protein-Based Biotherapeutics That Penetrates Cell-Membrane and Induces Anti-Angiogenic Effect - Improved Cell-Permeable Suppressor of Cytokine Signaling (iCP-SOCS3) Proteins, Polynucleotides Encoding the Same, and Anti-Angiogenic Compositions Comprising the Same
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15361701
|
Filing Dt:
|
11/28/2016
|
|
Publication #:
|
|
Pub Dt:
|
05/18/2017
| | | | |
|
Title:
|
CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF
|
|
|
Assignee
|
|
|
|
|
| 9TH FLOOR, 189 SUNGAM-RO, MAPO-GU |
| SEOUL, KOREA, REPUBLIC OF 03929 |
|
|
Correspondence name and address
|
| |
SUGHRUE MION PLLC
|
| |
2100 PENNSYLVANIA AVENUE, N.W.
|
| |
SUITE 800
|
| |
WASHINGTON, DC 20037-3213
|
Search Results as of:
09/25/2024 03:23 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
